Kadia Siddhartha insider trades
Kadia Siddhartha has filed 18 Form 4s with the SEC that we hold, for CELL (Chief Executive Officer, Director), NUVA (Director), Mesa Laboratories INC /CO/ (MLAB) (President and CEO) and ISO (Director). Across all of them we count 1 purchase worth $800.1K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($800.1K) and 0 sales ($0). The largest single trade was a purchase of 7,093 shares of Mesa Laboratories INC /CO/ worth $800.1K, dated 2026-08-13. The first filing on our record is dated 2021-09-09 and the latest 2026-08-17.
CELL
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
NUVA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Mesa Laboratories INC /CO/ (MLAB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-13 | P, purchase reported on Form 4 | 7,093 | $800.1K | 2026-08-17 |
ISO
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1573666) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms